Application of modified Bu-CTX2 preconditioning in allogenic hematopoietic stem cell transplantation

CLINICAL FOCUS ›› 2010, Vol. 25 ›› Issue (15): 1317-1320.

Application of modified Bu-CTX2 preconditioning in allogenic hematopoietic stem cell transplantation

WANG Zhi-ming;WANG Lin;CHEN Xiao-xia;LEI Mei-qing;LUO Xian-sheng;HE Li-li;FU Rong-xiang;WANG Yun-ying;LI Li-qiong;HUANG Zi-ying;TAN Lian;XU Dan-dan;LI Xing

Online:2010-08-05 Published:2010-08-05

Abstract

CLC Number:

R733.7

WANG Zhi-ming;WANG Lin;CHEN Xiao-xia;LEI Mei-qing;LUO Xian-sheng;HE Li-li;FU Rong-xiang;WANG Yun-ying;LI Li-qiong;HUANG Zi-ying;TAN Lian;XU Dan-dan;LI Xing. Application of modified Bu-CTX2 preconditioning in allogenic hematopoietic stem cell transplantation[J]. CLINICAL FOCUS, 2010, 25(15): 1317-1320.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/

https://huicui.hebmu.edu.cn/EN/Y2010/V25/I15/1317

[1]	Liu Lili, Yuan Yuting, Lai Gengliang, Tian Chuan, Lan Xiang, Ye Zhonglv. The relationship between minimal residual disease on day 15 and prognosis in children with acute lymphoblastic leukemia [J]. Clinical Focus, 2024, 39(1): 47-52.
[2]	. [J]. Clinical Focus, 2023, 38(10): 954-960.
[3]	Dong Zhengrong, Tao Qianshan, Shen Yuanyuan, Dong Yi. Analysis of the follow-up results of 163 patients with acute promyelocytic leukemia [J]. Clinical Focus, 2023, 38(9): 813-818.
[4]	Du Jiayi, Liu Lili, He Yongzhong, Tian Chuan, Lan Xiang, Ye Zhonglyu. Clinical observation of serious adverse events in children with acute lymphoblastic leukemia during chemotherapy [J]. Clinical Focus, 2023, 38(2): 149-154.
[5]	Yin Lingling, Wu Wenjian, Zhu Feng. Lineage switch from acute myeloid leukemia to acute lymphoblastic leukemia: A case report and literature review [J]. Clinical Focus, 2022, 37(11): 1025-1030.
[6]	Shen Ziyuan, Kang Haiquan, Sang Wei, Yan Dongmei. Analysis of bacterial distribution, resistance and risk factor of death of bacterial infection in leukemia patients [J]. Clinical Focus, 2021, 36(12): 1092-1096.
[7]	Ma Rui, Sun Yuqian. Standardized treatment of acute leukemia by haplo-identical stem cell transplantation [J]. Clinical Focus, 2021, 36(10): 869-873.
[8]	Lu Wenyi, Zhao Mingfeng. The standard treatment of acute lymphoblastic leukemia [J]. Clinical Focus, 2021, 36(10): 874-879.
[9]	Liu Qiaoxue, Wei Hui. Standardized treatment of acute myeloid leukemia [J]. Clinical Focus, 2021, 36(10): 880-883.
[10]	Qin Yazhen. Standardized detection of BCR-ABL mRNA and clinical application in patients with chronic myeloid leukemia [J]. Clinical Focus, 2021, 36(10): 884-888.
[11]	Wang Hui, Chen Man. Flow cytometry in minimal residual disease detection of acute myeloid leukemia: current status and progress [J]. Clinical Focus, 2021, 36(10): 889-895.
[12]	Liu Jianning, Sun Li, Niu Zhiyun, Wen Shupeng, Wang Ying, Zhang Xuejun, Wang Fuxu. Expression of PD-1 on T-lymphocytes in acute leukemia after allogeneic hematopoietic stem cell transplantation [J]. Clinical Focus, 2021, 36(3): 251-255.
[13]	. [J]. Clinical Focus, 2021, 36(2): 188-192.
[14]	Ren Jinhai;Guo Xiaoling;Cai Shengxin. Diagnosis and treatment of relapsed/refractory acute myeloid leukemia [J]. Clinical Focus, 2015, 30(10): 1100-1103.
[15]	Guo Xiaonan;Qiao Shukai. Standardized management of tyrosine kinase inhibitors therapy for patients with chronic myelogenous leukemia in clinic [J]. Clinical Focus, 2015, 30(10): 1104-1109.

Application of modified Bu-CTX2 preconditioning in allogenic hematopoietic stem cell transplantation

PDF (PC)

Knowledge

Cited

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments